Campanella, Gabriele
Hanna, Matthew G.
Geneslaw, Luke
Miraflor, Allen
Werneck Krauss Silva, Vitor
Busam, Klaus J.
Brogi, Edi
Reuter, Victor E.
Klimstra, David S.
Fuchs, Thomas J. http://orcid.org/0000-0001-7603-8687
Article History
Received: 23 October 2018
Accepted: 3 June 2019
First Online: 15 July 2019
Competing interests
: T.J.F. is the Chief Scientific Officer of Paige.AI. T.J.F. and D.S.K. are co-founders and equity holders of Paige.AI. M.G.H., V.W.K.S., D.S.K., and V.E.R. are consultants for Paige.AI. V.E.R. is a consultant for Cepheid. M.G.H. is on the medical advisory board of PathPresenter. D.S.K has received speaking/consulting compensation from Merck. G.C. and T.J.F. have intellectual property interests relevant to the work that is the subject of this paper. MSK has financial interests in Paige.AI. and intellectual property interests relevant to the work that is the subject of this paper.